Evidence for fractal correlation properties in variations of peripheral arterial tone during REM sleep. Am J Physiol Heart Circ Physiol 283: H434-H439, 2002. First published March 7, 2002 10.1152/ajpheart.00336.2001.-Previous studies utilizing detrended fluctuation analysis (DFA) of heart rate variability during sleep revealed a higher fractal exponent during rapid eye movement (REM) sleep than non-REM sleep. The aim of this study was to determine whether the same difference exists in the variations of peripheral arterial tone (PAT). Finger pulse wave measured by a novel plethysmographic technique was monitored during sleep in 12 chronic heart failure patients, 8 heavy snorers, and 12 healthy volunteers. For each subject, at least two 15-min time series were constructed from the interpulse intervals and from pulse wave amplitudes during REM and non-REM sleep. Fractal scaling exponents of both types of time series were significantly higher for REM than non-REM sleep in all groups. In each of the groups and in both sleep stages, the fractal scaling exponents based on pulse wave amplitude were significantly higher than those based on pulse rate variability. A repeat of the analysis for short-, intermediate-, and long-term intervals revealed that the fractallike exponents were evident only in the short-and intermediate-term intervals. Because PAT is a surrogate of sympathetic activation, our results indicate that variations in sympathetic activation during REM sleep have a fractallike behavior. detrended fluctuation analysis; congestive heart failure; heavy snoring DETRENDED FLUCTUATION ANALYSIS (DFA) has been used extensively for extracting hidden information from physiological time series, particularly from heart rate variability data (5-7). This has been successfully used in sleep. The fractal exponent of the electrocardiogramderived RR interval variability during rapid eye movement (REM) sleep, or dream sleep, was shown to be very similar to that during wakefulness, whereas it declined significantly during non-REM sleep (4, 17). Heart rate variability, however, is under the simultaneous control of both the sympathetic and parasympathetic branches of the autonomic nervous system. Therefore, it is not possible to determine whether the fractal correlation properties of heart rate variability reflect a unique interaction between the two branches of the autonomic regulating mechanisms or whether fractal correlations characterize the activity of only one of the branches. REM sleep is associated with augmented sympathetic activation relative to non-REM sleep, as determined by spectral analysis of heart rate variability (2, 3, 13) and by muscle sympathetic nerve recordings (16). Using a newly developed plethysmographic technique to measure peripheral arterial tone (PAT), we demonstrated that the PAT signal can be used as a sensitive surrogate of sympathetic activation during sleep. Transient attenuation of the PAT signal, indicating vasoconstriction, or increased sympathetic activation, accompanied apneas, hypopneas, and periodic leg movements during sleep (10, 15), and tonic attenuation accompanied REM sleep (9). Furthermore, transient deeper attenuation events associated with bursts of rapid eye movements, termed phasic REM events, were superimposed on the tonic PAT attenuation (11).
detrended fluctuation analysis; congestive heart failure; heavy snoring DETRENDED FLUCTUATION ANALYSIS (DFA) has been used extensively for extracting hidden information from physiological time series, particularly from heart rate variability data (5) (6) (7) . This has been successfully used in sleep. The fractal exponent of the electrocardiogramderived RR interval variability during rapid eye movement (REM) sleep, or dream sleep, was shown to be very similar to that during wakefulness, whereas it declined significantly during non-REM sleep (4, 17) . Heart rate variability, however, is under the simultaneous control of both the sympathetic and parasympathetic branches of the autonomic nervous system. Therefore, it is not possible to determine whether the fractal correlation properties of heart rate variability reflect a unique interaction between the two branches of the autonomic regulating mechanisms or whether fractal correlations characterize the activity of only one of the branches. REM sleep is associated with augmented sympathetic activation relative to non-REM sleep, as determined by spectral analysis of heart rate variability (2, 3, 13) and by muscle sympathetic nerve recordings (16) . Using a newly developed plethysmographic technique to measure peripheral arterial tone (PAT), we demonstrated that the PAT signal can be used as a sensitive surrogate of sympathetic activation during sleep. Transient attenuation of the PAT signal, indicating vasoconstriction, or increased sympathetic activation, accompanied apneas, hypopneas, and periodic leg movements during sleep (10, 15) , and tonic attenuation accompanied REM sleep (9) . Furthermore, transient deeper attenuation events associated with bursts of rapid eye movements, termed phasic REM events, were superimposed on the tonic PAT attenuation (11) .
In the present study we applied DFA to the PAT signal during REM sleep and sleep stage 3-4 (non-REM) sleep, and we demonstrate for the first time fractal correlation properties in PAT during REM sleep. We also show that the magnitude of the fractal exponent based on the PAT amplitude was higher than that based on pulse rate variability.
STUDY DESIGN
Subjects. Thirty-two subjects participated in this study (see Table 1 for selected demographic, clinical, and sleep data). Twelve chronic heart failure patients [CHF group; 9 men, 3 women; age 60.9 Ϯ 11.9 yr, body mass index (BMI) 25.9 Ϯ 4.6 kg/m 2 , 4 current smokers] with New York Heart Association score stage 3-4. Their mean ejection fraction was 22.36 Ϯ 4.63%. Five patients had Cheyne-Stokes respiration during sleep. The mean respiratory disturbance index (RDI, defined as total number of central apneas plus hypopneas divided by hours of sleep) was 34.6 Ϯ 21.9. Periodic breathing was associated with periodic oscillations in arterial oxygen saturation (Sa O 2 ). The mean saturation nadir was 85.5 Ϯ 6.5%. All medications [long-acting nitrates (7), ␤-blockers (7), angiotensin-converting enzyme inhibitors (12) , benzodiazepines (2)] were continued during the study, but none of the patients used ␣-blocking medications, which could affect PAT. The second group comprised eight adults (SN group; 3 men, 5 women; age 48.9 Ϯ 9.9 yr, BMI 27.5 Ϯ 5.3 kg/m 2 , 3 current smokers) who were referred to the Technion Sleep Laboratory because of suspected sleep apnea and were found to have only heavy snoring (mean RDI 4 Ϯ 3.25; none had a meaningful decrease in oxygen saturation). The third group comprised 12 healthy volunteers without any sleep disorders (Norm group; 9 men, 3 women; age 25.6 Ϯ 10.9 yr, BMI 21.9 Ϯ 2.7 kg/m 2 , 1 current smoker, RDI 7.6 Ϯ 5.4; none had any meaningful decrease in oxygen saturation). All participants were recorded in the sleep laboratory for either one or two nights. Wherever two nights were available, data from the second night were analyzed. All participants gave signed informed consent before being enrolled in the study, which was approved by the Institutional Human Subjects Review Committee.
Method. Polysomnographic recordings included electrooculography, electrocardiography, submental electromyography, electroencephalography (EEG, C3-A2), respiratory abdominal motion (respiratory belt), air flow (orobuccal thermistors), Sa O 2 (finger oximetry), body movements, and breathing sound intensity. All were recorded into computer memory after amplification and signal conditioning via a multichannel polygraph (EEG 4214; Nihon Kohden, Kogyo, Tokyo, Japan). Studies were performed from about 10-11 PM to 6 AM the following day. The polysomnographic signals were scored from the computer screen according to standard practice. The PAT signal was sampled at 128 Hz and digitized with the SITE PAT-200 (Itamar Medical, Cesarea, Israel). The data were automatically analyzed off-line as described below. First, polysomnographic data were conventionally scored for sleep stages (1, 2, 3-4, and REM) based on 30-s epochs. A 15-min sliding window with 1-min increments was then applied to the data, and the percentage of sleep stages was determined in each of the 15-min windows. Only windows containing 15 min of either REM or sleep stage 3-4 were selected for further analysis. In each window PAT pulses were digitally detected, artifacts and noise sections were removed (but not premature beats), and time series were constructed by concatenation of artifact-free PAT pulse sections 1) from the pulse period (difference of 2 locations of adjacent maxima) and 2) from the upstroke amplitude (the difference of maximum and its preceding minimum). Each subject could have multiple windows of either REM or stage 3-4 because of the 1-min increments of the sliding window. Windows containing at least 7.5 min (50%) of valid PAT pulses were included in the analysis. DFA (14) was performed on each of the time series (amplitude/pulse period) and averaged across all available REM and stage 3-4 windows. The average percentage of PAT pulses in each window that was included in the analysis was 94.9% Ϯ 7.3% (minimum 65%). The total number of windows was 1,375: 557 for REM and 818 for stage 3-4.
The DFA method is briefly described here. First, the original time series was integrated, and then detrending was performed locally, that is, the time series was subdivided into windows of equal length and, in each window, the local trend was subtracted. Standard deviations of the integrated and detrended time series were computed for windows of the same length, and the mean of the standard deviations of all windows of the same size (n) was computed. The above process was repeated over an increasing window size. The outcome of the DFA analysis was the fractal exponent ␣, which represents the slope, on a log-log scale, of a line fitted to the mean standard deviations vs. the window sizes across the relevant range of scales ( Fig. 1) . Because previous results of DFA applied to interbeat interval sleep data indicated that the fitted DFA plot was not strictly linear (4) but consisted of at least two regions with different slopes (crossover phenomenon), we calculated the scaling exponent ␣ for three different regions: a short-term interval time series over periods of 4-10 pulses (␣1), an intermediate-term interval from 10 to 100 pulses (␣2), and the long-term interval from 100 to 25% of the total number of PAT pulses in a window (ϳ250; ␣3). We also calculated the fractal exponent based on the entire range of 4-25% of the total number of pulses. Thus eight fractal exponents were calculated for each 15-min window, four based on the time series constructed from the pulse rate variability and four from the pulse amplitude variability. Each of the exponents was averaged across all available 15-min windows for each subject, for REM and stage 3-4 separately, to provide the final individual outcome measures.
Statistical analysis. Differences between the groups were assessed by analysis of variance followed by Duncan's multiple-range test for parametric variables and by KruskalWallace test for nonparametric variables. The fractal exponents are presented as means Ϯ SD. Because fractal exponents were normally distributed, analysis of covariance, followed by planned post hoc comparisons, was used to compare between the fractal exponents of REM and stage 3-4 and among the three groups. The fractal exponents based on the pulse amplitude ␣(pulsea) and pulse rate ␣(pulsev) vari- Values are means Ϯ SD. Norm, normal volunteers; SN, heavy snorers; CHF, chronic heart failure patients; BMI, body mass index; n, number. RDI, respiratory disturbance index.
ability were compared with t-tests. Pearson product-moment correlations were used to determine the relationship between the fractal exponents and age and BMI. Univariate analysis was followed by multiple stepwise regression analysis to predict ␣(pulsev) and ␣(pulsea) with sleep stage, group, age, gender, BMI, smoking, rates of hypertension and diabetes, and RDI as predictors. Logistic regression analysis, followed by calculation of the receiver-operating characteristic (ROC), was used to determine whether the fractal exponents could differentiate between the REM and stage 3-4 windows across all three groups. This was done separately for ␣(pulsev) and ␣(pulsea), as well as for both exponents combined.
RESULTS
There was no statistically significant difference in gender among the three groups ( 2 ϭ 3.74, P Ͻ 0.16). However, there was a statistically significant difference in age among the three groups, with the CHF group being older than the SN group, who were older than the Norm group (F ϭ 31.33, P Ͻ 0.0001). In addition, there was a statistically significant difference in BMI (F ϭ 4.89, P Ͻ 0.02). Post hoc Duncan's multiple-range test revealed that the Norm group was statistically significantly less obese than the other two groups. The CHF group had a higher prevalence of hypertension ( 2 ϭ 14.93, P Ͻ 0.0006) than the other two groups and a higher prevalence of diabetes than the Norm group ( 2 ϭ 9.88, P Ͻ 0.002). The three groups differed in the percentage of smokers ( 2 ϭ 6.59, P Ͻ 0.04) but not in the number of packs smoked per year. Post hoc testing revealed that the SN group had a larger percentage of smokers than the Norm group ( 2 ϭ 6.71, P Ͻ 0.02). There was a borderline statistically significant difference in minimum oxygen saturation among the three groups (Kruskal-Wallace test 2 ϭ 5.34, P Ͻ 0.07). Right: results of the fractal scaling analysis for the pulse interval and pulse amplitude time series. Note that in both cases the scaling exponent was higher in REM sleep and that the pulse amplitude exponents were higher than the pulse interval exponents in both sleep stages. PR, pulse rate.
␣(pulsev) and ␣(pulsea), which were based on the entire range, significantly increased in REM relative to stage 3-4 sleep ( Table 2) . It is also evident from Fig. 1 that there was a crossover point in the DFA plots at ϳ100 pulses, for both sleep stages, particularly in those based on pulse amplitudes, at which the fractal exponents became smaller. Table 3 presents the REM and stage 3-4 fractal exponents for the three groups determined separately for the short-, intermediateand long-term intervals. In almost all of the cases, both ␣(pulsea) and ␣(pulsev) were significantly higher in REM than in stage 3-4 sleep. In only a few cases were t-test results insignificant or bordering on statistical significance. Of note, both in REM and stage 3-4 sleep, ␣1(pulsea) was either slightly greater than 1.0 or very close to 1.0, indicating the existence of self-similar fluctuations over this range of time scales in PAT amplitude variability in both stages of sleep. The fractal exponents for the intermediate-term interval were close to 1.0 only during REM sleep, whereas for the long-term interval time series fractal exponents were much smaller than 1.0 in both sleep stages, which indicates the loss of fractallike behavior in intervals longer than 100 pulses.
In view of the consistency of the differences between REM and stage 3-4 sleep across the three regions, we used the ␣-exponent based on the entire region to compare the three groups as well as the two methods of calculating the exponents, i.e., interpulse variability vs. interamplitude variability. Because the groups significantly differed from each other with respect to age, BMI, smoking, and the rates of hypertension and diabetes, these variables were used as covariates. Analysis of covariance revealed significant differences between REM and stage 3-4 sleep for both ␣(pulsev) (F ϭ 39.45; P Ͻ 0.0001) and ␣(pulsea) (F ϭ 93.0; P Ͻ 0.0001) but no significant difference between the groups for either variable or any interaction between group and sleep stage. Across all groups there was a significant correlation between ␣(pulsea) and age in both REM sleep (0.52; P Ͻ 0.002) and stage 3-4 sleep (0.49; P Ͻ 0.004). Age was unrelated to ␣(pulsev), and there was no significant relationship between gender, BMI, smoking, hypertension, and diabetes and fractal exponents. The two fractal exponents were only marginally correlated with each other during stage 3-4 sleep (0.38, P Ͻ 0.028) and were unrelated during REM sleep (Ϫ0.03, not significant).
Multiple stepwise regression analysis confirmed the univariate analysis. The fractal exponent based on pulse amplitude variability could be predicted by sleep stage, which accounted for 54.7% (P Ͻ 0.0001) of the total variability, and age, which accounted for 11.8% (P Ͻ 0.0001) of the total variability; ␣(pulsev) was predicted only by sleep stage, accounting for 39.4% of the variability.
Comparison of the magnitude of the two fractal exponents revealed that ␣(pulsea) was significantly higher than ␣(pulsev) in all three groups and in both sleep stages (each comparison was significant at at least P Ͻ 0.0008). Likewise, using the two fractal exponents in a logistic regression analysis to differentiate REM from sleep stage 3-4 time series, we found a better discrimination when using ␣(pulsea) than ␣(pulsev), as indicated by a larger area under the ROC curve [95.2% (P ϭ 0.001) vs. 87.6% (P ϭ 0.005)]. The use of both fractal exponents in the regression analysis only slightly improved on these results (96%, P ϭ 0.001).
DISCUSSION
Our present results demonstrate that PAT, as measured by the pulse wave amplitude, shows fractal correlation properties similar to those reported previously in RR interval variability and, as found in the present study, also in pulse rate variability. The DFA technique quantifies the presence or absence of long-term correlations in a time series. A fractallike signal results in an ␣-value of ϳ1. Deviations from a value of 1.0 to either greater or smaller values indicate the breakdown of the long-term correlations in the data (14) . The finding that the short-term fractal exponents extracted from the variability in the PAT signal amplitude during REM sleep and stage 3-4 were closer to 1.0 may reflect the powerful modulation of cardiac activity by respiration in both sleep stages. This was evident in all Mean fractal exponents of pulse amplitude [␣(pulsea)] and pulse period [␣(pulsev)] for rapid eye movement (REM) and sleep stage 3-4 were calculated for the entire range of 4 pulses to 25% of the total no. of pulses in the window (0.25 ϫ N) . n, No. of subjects.
three of the groups, healthy controls, heavy snorers, and CHF patients. In contrast, in the intermediateterm time series, fractallike exponents were found only in REM sleep. These findings confirm and extend the results of Bunde et al. (4) and Togo and Yamamoto (17) , who reported on similar findings for DFA of heart rate variability data. No attempt, however, was made in those studies to differentiate between the contribution of short-and long-term regions to the fractal exponents. Furthermore, in agreement with the results of Bunde et al. (4) , who showed that apneic events during sleep did not influence the outcome of the DFA, episodes of Cheyne-Stokes breathing in CHF patients also did not influence our results. Regardless of the occurrence of disordered breathing during sleep, the magnitude of fractal exponent ␣ was higher by 17.7-29.1% during REM than during sleep stage 3-4.
A comparison of the fractal exponents among the three groups after adjustment for confounding variables revealed no significant differences in either fractal exponent. Previously, CHF patients were shown to have deviations from the normal value of ϳ1.0 in the fractal exponent of heart rate variability (1) . Although CHF patients in our study also showed the highest fractal exponent during REM sleep (1.11 vs. 1.06 and 1.02), this could be accounted for solely by the age difference between the groups. Age was significantly correlated with the fractal exponent based on pulse wave amplitude variability and was also found to be a significant predictor of this fractal exponent by stepwise multiple logistic regression. Previously, short-term fractal exponent of heart rate variability during wakefulness was shown to increase in aged individuals (18) . Of note, during sleep only the Mean ␣(pulsea) and ␣(pulsev) were calculated for short (4-10 pulses)-, intermediate (10-100 pulses)-, and long (100-0.25 ϫ N pulses)-term interval time series. ns, Not significant. exponent based on pulse amplitude variability was related to age.
In each of the groups and in both sleep stages, the magnitude of the fractal exponent based on the pulse wave amplitude variability was significantly higher than the exponent based on the pulse rate variability. Overall, it was higher by 40% and 32.5% during sleep stage 3-4 and REM, respectively. The results of the logistic regression analysis also indicated that the fractal exponent based on the pulse wave amplitude provided a better discrimination than the exponent based on pulse variability between REM and sleep stage 3-4 time series.
This suggests that the variations in pulse amplitudes behave more as a fractallike signal than the variations in pulse rate. Unlike heart rate variability, or its pulse wave surrogate, which reflects the interplay between sympathetic and vagal influences on the heart, the finger pulse wave amplitude measured with the PAT device is a sensitive surrogate of purely sympathetic activation. The peripheral vascular beds located at the distal parts of the limbs are major sites of sympathetic vasoconstrictor activity. This is particularly true of the soles of the feet, the plantar surfaces of the toes, and the palmar surfaces of the hands and fingers, where there is a high density of arteriovenous anastomoses and a correspondingly high density of ␣-adrenergic sympathetic innervation (12) . During wakefulness as well, increased sympathetic activation was shown to be associated with increasing magnitude of the fractal exponent of heart rate variability (18, 19) . Thus the pattern of sympathetic activation that modulates the peripheral tone during REM sleep is characterized by fractal correlation properties for intervals up to 100 pulses. The finding that the pulse rate variability and amplitude variability fractal exponents were uncorrelated during REM sleep and were only marginally correlated during sleep stage 3-4 may indicate that they reflect at least partially independent processes. On the basis of previous and present findings, it can be concluded that the fractal correlation properties of heart rate variability during REM sleep are primarily the result of the intense sympathetic activation during this sleep stage.
In conclusion, our present findings demonstrate that the regulation of PAT during REM sleep, which is a surrogate of sympathetic activation, behaves as a fractal signal. This behavior is similar to that of the heart rate variability and was found in healthy controls, in heavy snorers, and in CHF patients.
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